Deep learning‐based target metabolite isolation and big data‐driven measurement uncertainty estimation in proton magnetic resonance spectroscopy of the brain

Hyeong Hun Lee,Hyeonjin Kim
DOI: https://doi.org/10.1002/mrm.28234
2020-03-05
Magnetic Resonance in Medicine
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>The aim of this study was to develop a method for metabolite quantification with simultaneous measurement uncertainty estimation in deep learning‐based proton magnetic resonance spectroscopy (<sup>1</sup>H‐MRS). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>The reliability of metabolite quantification depends on signal‐to‐noise ratio (SNR), linewidth, and degree of spectral overlap (DSO), and therefore knowledge about these factors may be utilized in measurement uncertainty estimation in deep learning‐based <sup>1</sup>H‐MRS. While SNR and linewidth are typically estimated from a representative singlet, DSO needs to be estimated metabolite‐specifically. We developed convolutional neural networks (CNNs) capable of isolating target metabolite signal on simulated rat brain spectra at 9.4T, such that, in addition to metabolite content, the signal‐to‐background ratio (SBR) as a quantitative metric of DSO can be estimated directly from CNN‐output for each metabolite. The CNN‐predicted SBR was adjusted according to its pre‐defined relationship to the ground‐truth SBR by exploiting the big spectral data (N = 80 000), and used for measurement uncertainty estimation together with the SNR and linewidth from the CNN‐input spectrum. The proposed method was tested first on the simulated spectra in comparison with LCModel and jMRUI and further on in vivo spectra. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The proposed method outperformed LCModel and jMRUI in both quantitative accuracy and measurement uncertainty estimation. Using in vivo data, the metabolite concentrations from the proposed method were close to the reported ranges with the measurement uncertainty of glutamine, glutamate, myo‐inositol, N‐acetylaspartate, and Tau less than 10%.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>The proposed method may be used for metabolite quantification with measurement uncertainty estimation in rat brain at 9.4T by exploiting the spectral isolation capability of the CNNs and the availability of big spectral data.</p></section>
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?